Cargando…
P53及BCL2蛋白在双表达弥漫大B细胞淋巴瘤中的预后判断价值
OBJECTIVE: To investigate the strong expression (S+) of P53 and BCL2 proteins in MYC/BCL2 double-expression DLBCL (DEL) and whether they can be used for the prognostic evaluation and stratified diagnosis of DELs. METHODS: Tissue microarray were made by filed FFPE blocks of 174 DLBCL cases. The trans...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364905/ https://www.ncbi.nlm.nih.gov/pubmed/32397023 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.07.010 |
Ejemplares similares
-
弥漫大B细胞淋巴瘤患者蛋白表达检测的预后意义
Publicado: (2017) -
CARD11在弥漫大B细胞淋巴瘤中的表达及其预后意义
Publicado: (2016) -
166例双表达弥漫大B细胞淋巴瘤临床特征与预后分析
Publicado: (2022) -
Cereblon/CRBN在弥漫大B细胞淋巴瘤中的表达及其与预后的关系
Publicado: (2020) -
MYC及BCL-2蛋白双表达对弥漫大B细胞淋巴瘤患者预后影响:倾向性评分匹配分析
Publicado: (2022)